You can buy or sell KZR and other stocks, options, ETFs, and crypto commission-free!
Kezar Life Sciences, Inc. develops drugs to revolutionize the treatment of autoimmune disorders. It also discovers and develops new therapies targeting protein homeostasis. Read More The firm specializes in the areas of protein degradation and protein secretion to discover and develop novel therapies for the treatment of serious, unmet medical needs. Its product include KZR-616, a first-in-class selective immunoproteasome inhibitor, has completed testing in healthy volunteers . The company was founded by John Fowler, Christopher J. Kirk and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Associated PressMar 5
Kezar Life Sciences to Present at the Cowen and Company 39th Annual Health Care Conference
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs ...
-$0.44 per share
Expected Today, After Hours